thecronosgroup.com Open in urlscan Pro
2606:4700:20::681a:88e  Public Scan

Form analysis
0 forms found in the DOM

Text Content

Accessibility Screen-Reader Guide, Feedback, and Issue Reporting Skip to content
 * Brands
 * Education & Resources
   * Cannabis 101
   * Quality
   * Responsible Marketing
   * Resources
 * Pressroom
   * News Releases
   * Media Kit
 * Investors
   * Governance
     * Board of Directors
     * Committee Composition
     * Documents & Charters
   * Events & Presentations
   * Financial Information
     * EDGAR Filings
     * SEDAR Filings
     * Quarterly Results
     * Annual Reports
     * Annual Meeting
   * Stock Information
     * Stock Chart & Quote
     * Historical Price Lookup
     * Investment Calculator
     * Analyst Coverage
   * Investor Resources
     * Investor FAQ’s
     * Financial Tearsheet
     * Sign up for email alerts
     * Contact Investor Relations
 * Careers
 * Contact
   * Contact Us
   * Email Alerts

Menu
 * Brands
 * Education & Resources
   * Cannabis 101
   * Quality
   * Responsible Marketing
   * Resources
 * Pressroom
   * News Releases
   * Media Kit
 * Investors
   * Governance
     * Board of Directors
     * Committee Composition
     * Documents & Charters
   * Events & Presentations
   * Financial Information
     * EDGAR Filings
     * SEDAR Filings
     * Quarterly Results
     * Annual Reports
     * Annual Meeting
   * Stock Information
     * Stock Chart & Quote
     * Historical Price Lookup
     * Investment Calculator
     * Analyst Coverage
   * Investor Resources
     * Investor FAQ’s
     * Financial Tearsheet
     * Sign up for email alerts
     * Contact Investor Relations
 * Careers
 * Contact
   * Contact Us
   * Email Alerts

 * Brands
 * Education & Resources
   * Cannabis 101
   * Quality
   * Responsible Marketing
   * Resources
 * Pressroom
   * News Releases
   * Media Kit
 * Investors
   * Governance
     * Board of Directors
     * Committee Composition
     * Documents & Charters
   * Events & Presentations
   * Financial Information
     * EDGAR Filings
     * SEDAR Filings
     * Quarterly Results
     * Annual Reports
     * Annual Meeting
   * Stock Information
     * Stock Chart & Quote
     * Historical Price Lookup
     * Investment Calculator
     * Analyst Coverage
   * Investor Resources
     * Investor FAQ’s
     * Financial Tearsheet
     * Sign up for email alerts
     * Contact Investor Relations
 * Careers
 * Contact
   * Contact Us
   * Email Alerts

Menu
 * Brands
 * Education & Resources
   * Cannabis 101
   * Quality
   * Responsible Marketing
   * Resources
 * Pressroom
   * News Releases
   * Media Kit
 * Investors
   * Governance
     * Board of Directors
     * Committee Composition
     * Documents & Charters
   * Events & Presentations
   * Financial Information
     * EDGAR Filings
     * SEDAR Filings
     * Quarterly Results
     * Annual Reports
     * Annual Meeting
   * Stock Information
     * Stock Chart & Quote
     * Historical Price Lookup
     * Investment Calculator
     * Analyst Coverage
   * Investor Resources
     * Investor FAQ’s
     * Financial Tearsheet
     * Sign up for email alerts
     * Contact Investor Relations
 * Careers
 * Contact
   * Contact Us
   * Email Alerts


 * Brands
 * Education & Resources
   * Cannabis 101
   * Quality
   * Responsible Marketing
   * Resources
 * Pressroom
   * News Releases
   * Media Kit
 * Investors
   * Governance
     * Board of Directors
     * Committee Composition
     * Documents & Charters
   * Events & Presentations
   * Financial Information
     * EDGAR Filings
     * SEDAR Filings
     * Quarterly Results
     * Annual Reports
     * Annual Meeting
   * Stock Information
     * Stock Chart & Quote
     * Historical Price Lookup
     * Investment Calculator
     * Analyst Coverage
   * Investor Resources
     * Investor FAQ’s
     * Financial Tearsheet
     * Sign up for email alerts
     * Contact Investor Relations
 * Careers
 * Contact
   * Contact Us
   * Email Alerts

Menu
 * Brands
 * Education & Resources
   * Cannabis 101
   * Quality
   * Responsible Marketing
   * Resources
 * Pressroom
   * News Releases
   * Media Kit
 * Investors
   * Governance
     * Board of Directors
     * Committee Composition
     * Documents & Charters
   * Events & Presentations
   * Financial Information
     * EDGAR Filings
     * SEDAR Filings
     * Quarterly Results
     * Annual Reports
     * Annual Meeting
   * Stock Information
     * Stock Chart & Quote
     * Historical Price Lookup
     * Investment Calculator
     * Analyst Coverage
   * Investor Resources
     * Investor FAQ’s
     * Financial Tearsheet
     * Sign up for email alerts
     * Contact Investor Relations
 * Careers
 * Contact
   * Contact Us
   * Email Alerts

 * Brands
 * Education & Resources
   * Cannabis 101
   * Quality
   * Responsible Marketing
   * Resources
 * Pressroom
   * News Releases
   * Media Kit
 * Investors
   * Governance
     * Board of Directors
     * Committee Composition
     * Documents & Charters
   * Events & Presentations
   * Financial Information
     * EDGAR Filings
     * SEDAR Filings
     * Quarterly Results
     * Annual Reports
     * Annual Meeting
   * Stock Information
     * Stock Chart & Quote
     * Historical Price Lookup
     * Investment Calculator
     * Analyst Coverage
   * Investor Resources
     * Investor FAQ’s
     * Financial Tearsheet
     * Sign up for email alerts
     * Contact Investor Relations
 * Careers
 * Contact
   * Contact Us
   * Email Alerts

Menu
 * Brands
 * Education & Resources
   * Cannabis 101
   * Quality
   * Responsible Marketing
   * Resources
 * Pressroom
   * News Releases
   * Media Kit
 * Investors
   * Governance
     * Board of Directors
     * Committee Composition
     * Documents & Charters
   * Events & Presentations
   * Financial Information
     * EDGAR Filings
     * SEDAR Filings
     * Quarterly Results
     * Annual Reports
     * Annual Meeting
   * Stock Information
     * Stock Chart & Quote
     * Historical Price Lookup
     * Investment Calculator
     * Analyst Coverage
   * Investor Resources
     * Investor FAQ’s
     * Financial Tearsheet
     * Sign up for email alerts
     * Contact Investor Relations
 * Careers
 * Contact
   * Contact Us
   * Email Alerts




A GLOBAL
CANNABINOID COMPANY

Cronos Group is an innovative global cannabinoid company committed to building
disruptive intellectual property by advancing cannabis research, technology, and
product development. With a passion to responsibly elevate the consumer
experience, Cronos is building an iconic brand portfolio. Cronos’ diverse
international brand portfolio includes Spinach®, PEACE NATURALS® and Lord
Jones®.

Explore Brands arrow_forward Explore Solutions →


ABOUT


US






THE


TEAM

Our management team comprises experts in their fields, with a goal to establish
the most valuable international cannabis company. They are passionate, daring
people, driven by quality and integrity, who are determined to write history,
not read about it.
Mike Gorenstein
Jeff Jacobson
Shannon Buggy
Terry Doucet
James Holm
Anna Shlimak
Arye Weigensberg
Adam Wagner
Mike Gorenstein


MIKE GORENSTEIN

CHAIRMAN, PRESIDENT AND CHIEF EXECUTIVE OFFICER

Mike Gorenstein serves as Cronos Group’s Chairman, President and Chief Executive
Officer, he also serves as Chairman of Cronos Group’s Board of Directors. In
addition, Mr. Gorenstein is a Co-Founder and passive Member of Gotham Green
Partners. Before joining Cronos, Mike was the Vice President and General Counsel
at Alphabet Partners, LP, a New York City based multi-strategy investment
management firm, focused on identifying mispriced assets across various
industries, asset classes and geographies. Prior to Alphabet Partners, LP, he
was a corporate attorney at Sullivan & Cromwell LLP, where he focused on mergers
and acquisitions and capital markets transactions. Mike graduated from the
University of Pennsylvania Law School with a Juris Doctor, the Wharton School at
University of Pennsylvania with a certificate in Business Economics and Public
Policy and the Kelley School of Business at Indiana University with a Bachelor
of Science of Business in Finance.

Jeff Jacobson


JEFF JACOBSON

CHIEF GROWTH OFFICER

As Chief Growth Officer, Jeff leads the Marketing, Innovation, Operations and
Sales team in North America as well as the Consumer Insights and Data Analytics
teams for Cronos Group’s global business. Jeff sets the strategy for our brands
and is responsible for leading our global teams to help execute Cronos Group’s
vision. Jeff previously served as Cronos Group’s General Manager of Canada and
Europe. Before joining Cronos Group, Jeff founded a Toronto based marketing
agency and successfully launched and licensed several innovative software
products in the mobile industry. As a co-founder of Peace Naturals, Jeff’s
expertise and experience in licensing and compliance, new business development,
project management and resource management help Cronos Group lead in a variety
of markets.
Shannon Buggy


SHANNON BUGGY

SENIOR VICE PRESIDENT, GLOBAL HEAD OF PEOPLE

Shannon serves as the SVP, Global Head of People for Cronos Group where she
leads HR strategy across the Company’s global operations. Prior to Cronos Group,
Shannon was the Senior Vice President of Global Human Resources for Nielsen
where she led HR strategy for Nielsen Media. With over 25 years of experience,
Shannon has a proven track record of leading and managing global human resources
teams and driving excellence in talent acquisition, development, retention,
employee relations, compensation, benefits, talent management and labor
relations. Shannon holds a certification as a Senior Professional in Human
Resources from the HR Certification Institute. She graduated magna cum laude
with a Bachelor of Science degree in Human Resources Management from the Pace
University, Lubin School of Business.
Terry Doucet


TERRY DOUCET

GENERAL COUNSEL AND CORPORATE SECRETARY

Terry Doucet serves as Cronos Group’s General Counsel and Corporate Secretary.
In this capacity, he manages all legal and regulatory affairs at Cronos Group
and also serves as the Company’s Corporate Secretary. Prior to joining Cronos,
Terry was a corporate lawyer at Davies Ward Phillips & Vineberg LLP in Toronto,
where he focused primarily on M&A in large, complex and cross-border
transactions across numerous industries, as well as securities, corporate
finance and lending transactions. During that time, Terry was also seconded to
RBC Capital Markets, where he supported the bank’s derivative trading desks.
Terry is an Ontario-qualified lawyer, holding a Juris Doctor from the University
of Toronto and a joint honours (first class) Bachelor of Arts degree from McGill
University in Montreal.
James Holm


JAMES HOLM

CHIEF FINANCIAL OFFICER

James Holm serves as Cronos’ Chief Financial Officer. Before joining Cronos,
James served as Global Vice President of Finance Transformation at Vertiv and
before that he served as Americas Controller from September 2018 to February
2022. Prior to his roles at Vertiv, James served as Worldpay’s Finance Leader,
Finance Solutions & Process Transformation Organization from May 2016 to
September 2018. Before that, James served at Procter & Gamble in a variety of
finance roles from September 2008 to March 2016. James is a Certified Public
Accountant and Chartered Global Management Accountant who previously worked as
an external auditor for PricewaterhouseCoopers where he worked on various public
client engagements, which included working with Fortune 500 companies. He holds
a Master of Business Administration (MBA) with a Finance concentration and a
Bachelor of Science in Business in Accounting and Finance, both from Wright
State University.
Anna Shlimak


ANNA SHLIMAK

SENIOR VICE PRESIDENT, CORPORATE AFFAIRS AND STRATEGY

Anna is Cronos Group’s Senior Vice President of Corporate Affairs and Strategy
and is responsible for managing and directing the organization’s internal and
external communications, government affairs, corporate strategy and investor
relations. Prior to joining Cronos Group, Anna was the Head of Investor
Relations at Quest Partners LLC, a research-driven alternative investment firm.
Anna was responsible for business development, investor reporting, marketing and
communication initiatives for the fund. Previously, Anna held a range of diverse
roles at the New York Stock Exchange in both the New York and London offices.
Most recently, Anna was Head of Investor Relations within the Corporate Affairs
Group, where she was responsible for managing relationships with investors and
sell-side analysts and developing investor communications and reporting. She
received a Master of Business Administration (MBA) from Columbia Business School
and holds a Bachelor of Science in Economics from The Wharton School at the
University of Pennsylvania.
Arye Weigensberg


ARYE WEIGENSBERG

HEAD OF RESEARCH AND DEVELOPMENT

As Head of Research and Development, Arye is responsible for leading Cronos’
innovation program, where he oversees research and technology functions, and
leads scientific efforts to unlock the potential of rare cannabinoids. Before
joining Cronos, Arye was the CEO of Altria Israel Ltd, an Altria research and
development innovation hub. Arye joined Altria as part of its acquisition of
Green Smoke, where he was the Director of Marketing and Brand Management. Prior
to Green Smoke, Arye held a variety of roles in brand management and marketing,
supporting food brands such as Manischewitz, Lawry’s, Ragu, Knorr and Country
Crock. Arye graduated from Concordia University’s John Molson School of Business
with a Bachelor of Commerce in Marketing and International Business.
Adam Wagner


ADAM WAGNER

SVP, HEAD OF CRONOS ISRAEL

Adam Wagner serves as Senior Vice President, Head of Cronos Israel. Adam
oversees the business and strategy of Cronos Israel. Before he was appointed as
Head of Cronos Israel, he was the VP of Finance at Cronos Israel where he
oversaw the regional Israel finance department, including FP&A, controllership,
audit, treasury, tax, as well as IT, supply chain and procurement . Before
joining Cronos, Adam worked as a Director of Finance at Motus GI, a publicly
traded medical device company, where he oversaw the Israel-based finance
department. Before that, Adam was a Finance Manager at Medtronic, a publicly
traded medical equipment manufacturer, where he oversaw the Israel-based finance
department functions. Prior to Medtronic’s acquisition, he was the Corporate
Controller for Mazor Robotics, a dual-listed public medical device company. Adam
began his career as a Senior Auditor at EY where he managed a team that
performed audits for various publicly traded and private companies. Adam also
serves as a Finance expert on an advisory board for a wellness and healthcare
start-up. Adam is a CPA (Israel) and studied Accounting at Bar-Ilan University.
Adam also holds a Bachelor’s Degree in Science of Nutrition and his Master of
Science in Genetics and Biochemistry from Tel Aviv University.

 * Terms of Use
 * Privacy Policy
 * Cookie Policy

 * Terms of Use
 * Privacy Policy
 * Cookie Policy

© 2024 The Cronos Group. All rights reserved.
Facebook X-twitter Linkedin
 * Terms of Use
 * Privacy Policy
 * Cookie Policy

 * Terms of Use
 * Privacy Policy
 * Cookie Policy

© 2024 The Cronos Group. All rights reserved.
Facebook X-twitter Linkedin